BRD4 and cancer: However, in the primary colon epithelial cells (“pEpi1/2,” from two donors18), A1874 (100 nM) treatment failed to decrease cell viability (Fig. 2l) and induce apoptosis activation (Fig. 2m), indicating a cancer cell-specific effect by the BRD4-degrading PROTAC.